NasdaqGS - Delayed Quote USD
Quince Therapeutics, Inc. (QNCX)
1.0400
0.0000
(0.00%)
At close: May 30 at 4:00:00 PM EDT
1.0400
0.00
(0.00%)
After hours: May 30 at 5:57:37 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.2 | -0.04 | -0.61 | -0.11 |
| Low Estimate | -0.2 | -0.04 | -0.61 | -0.11 |
| High Estimate | -0.2 | -0.04 | -0.61 | -0.11 |
| Year Ago EPS | -- | -0.13 | -0.92 | -0.61 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -- | -0.1 | -0.1 | -0.23 |
| EPS Actual | -0.64 | -0.13 | -0.28 | -0.34 |
| Difference | -- | -0.03 | -0.18 | -0.11 |
| Surprise % | -- | -30.00% | -180.00% | -47.83% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.2 | -0.04 | -0.61 | -0.11 |
| 7 Days Ago | -0.22 | -0.05 | -0.54 | -0.13 |
| 30 Days Ago | -0.22 | -0.05 | -0.54 | -0.13 |
| 60 Days Ago | 0 | 0 | -0.31 | -0.14 |
| 90 Days Ago | 0 | 0 | -0.31 | -0.14 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | 1 |
| Up Last 30 Days | 1 | 1 | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| QNCX | -- | 69.23% | 33.52% | 81.97% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 3/25/2025 |
| Initiated | Oppenheimer: Outperform | 3/24/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/5/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/2/2025 |
| Initiated | Brookline Capital: Buy | 12/18/2024 |
| Maintains | D. Boral Capital: Buy to Buy | 11/14/2024 |
Related Tickers
CMPX Compass Therapeutics, Inc.
2.1000
-0.94%
LPTX Leap Therapeutics, Inc.
0.3780
+0.85%
CNTX Context Therapeutics Inc.
0.5771
-6.50%
SLRX Salarius Pharmaceuticals, Inc.
0.7629
-3.43%
PMN ProMIS Neurosciences, Inc.
0.5200
+3.17%
VRCA Verrica Pharmaceuticals Inc.
0.4946
-9.23%
TARA Protara Therapeutics, Inc.
3.0400
-2.88%
APRE Aprea Therapeutics, Inc.
1.7400
-2.79%
CLSD Clearside Biomedical, Inc.
0.7610
-2.44%
KRON Kronos Bio, Inc.
0.6750
+0.52%